About this event

  • Date and time Thu 21 Sep 2023 from 8:30am to 5:00pm
  • Location Royal Society of Medicine
  • Organised by Nephrology

This meeting is a collaboration between RSM Nephrology and Kidney Research UK Glomerulonephritis (GN) Clinical Study Group (CSG), updating on advancements in basic science, therapeutic targets, and clinical trials in glomerulonephritis. Topics will be reviewed and delivered through lectures, case based and panel discussions.

The primary aim of this educational meeting is to highlight advances in basic science, therapeutics, and clinical practices in the field of glomerulonephritis. This is the second day of this two-day event, to also register for the first day click here

Benefits of attending:

  • Gain an increased awareness of developments in refining definitions of disease entities in inflammatory renal diseases
  • Understand the pathological mechanisms and therapeutic targets in Glomerulonephritis
  • Enhance your knowledge of management strategies for Glomerulonephritis

Follow us on
Facebook 
Instagram
LinkedIn
Twitter 
YouTube  

We would like to thank our sponsors and exhibitors Britannia Pharmaceuticals and CSL Vifor for their support of this meeting. This activity has also been supported by Alpine Immune Sciences, argenx, Arrowhead Pharmaceutical, Chinook Therapeutics, Otsuka, Vera Therapeutics in the form of educational grants.

Due to this funding, the Nephrology Section is pleased to offer this event at a subsidised fee for participants.

Show Virtual / In Person rates

Agenda

View the programme (In person)

Registration, tea and coffee
Welcome and introduction

Dr Allyson Egan, President, Nephrology Section, Royal Society of Medicine

Epidemiology, innovation and novel treatment targets

Chair: Dr Allyson Egan and Dr Chee Kay Cheung

Outcome of Glomerulonephritis from the National Registry of Rare Kidney Diseases (RaDaR)

Professor Danny Gale

Machine Learning: Pathomics and the future for kidney biopsies

Professor Peter Boor

Complement: Therapeutic milestone in glomerular diseases

Professor David Kavanagh

B cell targets in glomerular diseases

Professor Onno Teng

Tea and coffee break

Therapeutic advancements in glomerular disease

Chair: Dr Rona Smith and Dr Steve McAdoo

Immunoglobulin A (IgA) Nephropathy

Professor Jonathan Barratt

Vasculitis

Dr Allyson Egan

Complement 3 (C3) Glomerulopathy

Dr Edwin Wong

Lupus Nephritis

Dr Ruth Pepper, Consultant Nephrologist, University College London Honorary Senior Lecturer, Royal Free London NHS Foundation Trust

Paediatric Glomerulonephritis

Dr Louise Oni

Lunch break

Nephrotic Syndrome: From bench to bedside

Chair: Dr Megan Griffith and Dr Ruth Pepper

Membranous Nephropathy

Professor Pierre Ronco

Minimal Change Disease (MCD) and Focal Segmental Glomerulosclerosis (FSGS) in children

Professor Moin Saleem

MCD and FSGS in adults

Dr Lisa Willcocks

Tea and coffee break

Cases and controversies

Chair: Professor Terry Cook and Dr Silke Brix

Cases and expert panel discussion

Professor Pierre Ronco, Professor Alan Salama, Professor Liz Lightstone, Dr Louise Oni and Professor Onno Teng

Closing remarks

Dr Rachel Jones, Professor Jonathan Barratt and Dr Allyson Egan

Completion of evaluation forms
Close of meeting
View the programme (Virtual)

Welcome and introduction

Dr Allyson Egan, President, Nephrology Section, Royal Society of Medicine

Epidemiology, innovation and novel treatment targets

Chair: Dr Allyson Egan and Dr Chee Kay Cheung

Outcome of Glomerulonephritis from the National Registry of Rare Kidney Diseases (RaDaR)

Professor Danny Gale

Machine Learning: Pathomics and the future for kidney biopsies

Professor Peter Boor

Complement: Therapeutic milestone in glomerular diseases

Professor David Kavanagh

B cell targets in glomerular diseases

Professor Onno Teng

Comfort break

Therapeutic advancements in glomerular disease

Chair: Dr Rona Smith and Dr Steve McAdoo

Immunoglobulin A (IgA) Nephropathy

Professor Jonathan Barratt

Vasculitis

Dr Allyson Egan

Complement 3 (C3) Glomerulopathy

Dr Edwin Wong

Lupus Nephritis

Dr Ruth Pepper, Consultant Nephrologist, University College London Honorary Senior Lecturer, Royal Free London NHS Foundation Trust

Paediatric Glomerulonephritis

Dr Louise Oni

Lunch break

Nephrotic Syndrome: From bench to bedside

Chair: Dr Megan Griffith and Dr Ruth Pepper

Membranous Nephropathy

Professor Pierre Ronco

Minimal Change Disease (MCD) and Focal Segmental Glomerulosclerosis (FSGS) in children

Professor Moin Saleem

MCD and FSGS in adults

Dr Lisa Willcocks

Comfort break

Cases and controversies

Chair: Professor Terry Cook and Dr Silke Brix

Cases and expert panel discussion

Professor Pierre Ronco, Professor Alan Salama, Professor Liz Lightstone, Dr Louise Oni and Professor Onno Teng

Closing remarks

Dr Rachel Jones, Professor Jonathan Barratt and Dr Allyson Egan

Completion of evaluation forms
Close of meeting

Sponsors

Location

Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom

 

Registration for this event will close at 1:00am on Wednesday 20 September 2023. Late registrations will not be accepted.

The agenda is subject to change at any time

If the event is recorded, we are only able to share presentations that we have received permission to share. There is no guarantee that all sessions will be available after the event, this is at the presenter’s and RSM’s discretion.

All views expressed at this event are of the speakers themselves and not of the Royal Society of Medicine, nor the speaker's organisations.

This event will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.

Domus reception

While you’re attending this event

Stay in the comfort of our hotel, Domus Medica, or hire one of our private dining rooms to socialise with your peers.

RSM members enjoy access to our enviable club facilities. For more information, please contact our team at domus@rsm.ac.uk or restaurant@rsm.ac.uk.

Find out more